After analyzing the binding mode of compound 7 and BRD4 through molecular docking, we believed that proper structural modification of compound 7 could improve its binding ability with BRD4 to obtain potent BRD4 inhibitors, which was conducive to our next research on anti-breast cancer. Here, BRD4 is linked to breast carcinoma.